Description
Motilium may be prescribed for the short-term treatment of diabetic gastroparesis or for managing nausea and vomiting that have not responded to other medications.
Diabetic gastroparesis is a chronic complication of diabetes characterized by damage to the gastrointestinal (GI) nerves due to high blood sugar levels. Motilium is typically prescribed once diabetes management has stabilized through dietary changes, exercise, and other medications.
Domperidone, the active ingredient in Motilium, functions by inhibiting dopamine receptors within the GI tract. Dopamine receptors play a role in regulating muscle contractions in the stomach and intestines. By blocking these receptors, Motilium enhances the movement of food through the GI tract
